Hap Trading, LLC Idera Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.74 $6,560 - $15,170	-20,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.41 - $0.7 $8,405 - $14,349	20,500 New	20,500 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.53 - $1.03 $9,169 - $17,819	-17,300 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$1.0 - $1.18 $4,400 - $5,192	4,400 Added 34.11%	17,300 $1,000
Q2 2021 Aug 11, 2021	SELL	$1.01 - $1.58 $4,646 - $7,268	-4,600 Reduced 26.29%	12,900 $3,000
Q1 2021 May 14, 2021	BUY	$1.23 - $5.98 $4,551 - $22,126	3,700 Added 26.81%	17,500 $1,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $28,841 - $71,484	13,800 New	13,800 $17,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.